An epidemic of pneumonia of viral appearance and of unknown etiology emerged in the city of Wuhan (Hubei province, China) in December 2019. On January 9, 2020, the discovery of a new coronavirus (first called 2019-nCoV, then SARS-CoV-2) was officially announced by the Chinese health authorities and the World Health Organization (WHO). This coronavirus is the agent responsible for the new infectious respiratory disease called Covid-19 (CoronaVIrus Disease 2019).

RESEARCH PROJECTS

The Institut Pasteur (Paris) and the Institut Pasteur International Network have been extremely active worldwide in responding with science to the pandemic caused by the SARS-CoV-2 coronavirus, responsible for Covid-19 disease.

See all projects

ALL OUR COVID-19 NEWS

Here are the news, press releases and videos from the Institut Pasteur (Paris), which was mobilized as soon as the first cases were announced, following the declaration of the epidemic by the Chinese authorities.

2020.07.15

Type 1 Interferon deficiency: A blood based Signature for Detecting Patients at risk of severe Covid-19 for a therapeutic approach

Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the individual management and prognosis of patients. In a study published in Science on July 13, teams from AP-HP, Inserm, Université of Paris, Institut Pasteur and Institut Imagine describe a unique and unexpected immunological phenotype in severe and critical patients, consisting of a severely impaired response of interferon (IFN) type I, associated with a persistent blood viral load and an excessive inflammatory response.

2020.07.06

COVID-19: no cross-protective immunity conferred by other coronaviruses in children

Every winter, seasonal coronaviruses are responsible for repeated colds and bronchitis from early childhood onwards. The question of whether the four seasonal coronaviruses can confer cross-protective immunity for COVID-19 was recently raised when it was demonstrated that some individuals had antibodies and immunity cells recognizing the SARS-CoV-2 virus before it was in active circulation. The existence of such immunity would have a major impact on our understanding of how the outbreak is likely to develop.

Coronavirus - SARS-CoV - SRAS - Institut Pasteur

2020.01.22

SARS-CoV-2 : le rôle de l’Institut Pasteur dans la surveillance du virus 2019 n-CoV apparu en Chine (in French)

Dans le cadre de sa mission de surveillance des virus respiratoires sur le territoire français, l’Institut Pasteur mobilise ses équipes, notamment via le centre national de référence (CNR) des virus des infections respiratoires. Son rôle est d’identifier et confirmer les suspicions d’infection respiratoires aiguës liées au nouveau coronavirus apparu à Wuhan, en Chine, en décembre 2019, et dont le bilan s’alourdit chaque jour en ce début d’année.

All the COVID-19 news

Covid-19 disease fact sheet (novel coronavirus)

Fiche Maladie Covid-19 - Institut Pasteur

All the information about Covid-19 disease, caused by the SARS-CoV-2 coronavirus (cause, symptoms, transmission, prevention, treatment, etc.). The Covid-19 fact sheet is updated regularly.

Read the disease fact sheet